Advertisement

Topics

Heron Announces Initiation Of Phase III Program For HTX-011 In Postoperative Pain Following Successful End-Of-Phase II Meeting With FDA

20:00 EDT 9 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Heron Announces Initiation Of Phase III Program For HTX-011 In Postoperative Pain Following Successful End-Of-Phase II Meeting With FDA

NEXT ARTICLE

More From BioPortfolio on "Heron Announces Initiation Of Phase III Program For HTX-011 In Postoperative Pain Following Successful End-Of-Phase II Meeting With FDA"

Quick Search
Advertisement